Chen, C.-H.; Hu, T.-H.; Wang, J.-H.; Lai, H.-C.; Hung, C.-H.; Lu, S.-N.; Peng, C.-Y.
A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral Therapy. Cancers 2022, 14, 5063.
https://doi.org/10.3390/cancers14205063
AMA Style
Chen C-H, Hu T-H, Wang J-H, Lai H-C, Hung C-H, Lu S-N, Peng C-Y.
A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral Therapy. Cancers. 2022; 14(20):5063.
https://doi.org/10.3390/cancers14205063
Chicago/Turabian Style
Chen, Chien-Hung, Tsung-Hui Hu, Jing-Houng Wang, Hsueh-Chou Lai, Chao-Hung Hung, Sheng-Nan Lu, and Cheng-Yuan Peng.
2022. "A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral Therapy" Cancers 14, no. 20: 5063.
https://doi.org/10.3390/cancers14205063
APA Style
Chen, C.-H., Hu, T.-H., Wang, J.-H., Lai, H.-C., Hung, C.-H., Lu, S.-N., & Peng, C.-Y.
(2022). A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral Therapy. Cancers, 14(20), 5063.
https://doi.org/10.3390/cancers14205063